Live
- RG Kar protest: Junior doctors to render medical services, carry out hunger strike in parallel
- Traffic Violators Counseled by Nagarkurnool Police
- Bathukamma Celebrations at Government Boys Junior College
- I Will Stand by the Mudiraj Community - MLA Dr. Rajesh Reddy
- Mission Bhagiratha DEE Hemalatha Distributes Certificates to Water Assistants in Achampet
- Elderly Man Dies Suddenly at Bus Stand
- DMK MP Wilson's conduct a threat to judicial impartiality and independence: BJP
- Lightning strikes claim nearly 300 lives in Bangladesh
- Haryana polls: Sohna records highest voting at 68.6 pc, Gurgaon registers lowest turnout
- Multiple attacks in Syria result in casualties
SII's Covovax gets WHO nod
SII’s Covovax gets WHO nod
Highlights
The World Health Organisation (WHO) on Friday issued an emergency use listing to Covovax, Serum Institute of India's version of Novavax Inc's Covid-19 vaccine.
New Delhi: The World Health Organisation (WHO) on Friday issued an emergency use listing to Covovax, Serum Institute of India's version of Novavax Inc's Covid-19 vaccine.
The WHO in a press release said, "Today, the World Health Organization issued an emergency use listing (EUL) for NVX-CoV2373, expanding the basket of WHO-validated vaccines against the SARS-CoV-2 virus.
The vaccine, named Covovax, is produced by the Serum Institute of India under licence from Novavax and is part of the COVAX facility portfolio, giving a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries."
Next Story
ADVERTISEMENT
